[Source: Research & Innovation] There is overwhelming evidence that diverse teams deliver stronger and more sustainable results in science and
Archives
The Art of the Biotech Deal at BIO CEO & Investor Conference
Professionals from all areas of biotechnology convened for the 20th annual BIO CEO & Investor Conference held at New York’s
Nabriva Therapeutics (NBRV) & Prana Biotechnology (NASDAQ:PRAN) Head to Head Review
Nabriva Therapeutics (NASDAQ: NBRV) and Prana Biotechnology (NASDAQ:PRAN) are both small-cap medical companies, but which is the superior investment? We
Stop Measuring These Vanity Metrics in Your Marketing Campaign
There is without a doubt no shortage of data for each action you take in your marketing campaigns, nor is
Vertex Pharma Gets FDA Approval for Combo CF Drug, Sets $292,000 Price
The FDA has approved a new Vertex Pharmaceuticals cystic fibrosis drug, clearing the way for the Boston company to bring
CRISPR Therapeutics’ Lundberg Steps Down as Chief Scientific Officer
Bill Lundberg is leaving his position as chief scientific officer of CRISPR Therapeutics (NASDAQ: CRSP). CRISPR Therapeutics, which has operations
Research Headlines – Targeting leukaemia with personalised treatment
[Source: Research & Innovation] EU-funded researchers are developing a personalised dosing solution for chemotherapy targeting leukaemia using advanced microfluidic chips
#BIOCEO18: Paradigm Shift Creating New Opportunities in China
The past few years have been a time of tremendous change in the world’s second largest market for biopharmaceuticals: China.
Better Health and care, economic growth and sustainable health systems
[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-SC1-BHC-2018-2020Pillar: Societal ChallengesPlanned Opening Date: Deadline: Tue, 2 Oct 2018 17:00:00 (Brussels local time)Modification Date: Sun, 11
SME Instrument
[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-EIC-SMEInst-2018-2020Pillar: Industrial LeadershipOpening Date: Deadline: Wed, 5 Sep 2018 17:00:00 (Brussels local time)Modification Date: Sat, 10 Feb